The biopsy sample resulted in amyloid protein identification by mass spectrometry showing amyloidosis, insulin-type (AIns), consistent with iatrogenic localized amyloidosis associated with insulin injection areas in diabetic patients [9]. The gene discussed is INS; the disease is amyloidosis.